Xenogesis Company
CRO specialised in preclinical drug metabolism & pharmacokinetics (DMPK), quantitative bioanalysis and expert interpretation.
Estimated Revenue:
$1M to $10M
Funding Status:
M&A
Employee Number:
11-50
Industry:
PharmTech
Headquarters:
Nottingham, Nottingham, United Kingdom
Founded Date:
2011
Technology:
Anti-infective Drugs